Source: MarketScreener

Nichi-Iko Pharmaceutical: Nov. 15, 2022TSE Designation of Securities Under Supervision (Confirmation): Nichi-Iko Pharmaceutical Co.,Ltd.

(marketscreener.com) Market News Nov. 15, 2022 TSEDesignation of Securities Under Supervision : Nichi-Iko Pharmaceutical Co.,Ltd. Tweet TSE has designated an issue as Securities Under Supervision as follows. ...https://www.marketscreener.com/quote/stock/JAPAN-EXCHANGE-GROUP-INC-12249999/news/Nov-15-2022TSE-Designation-of-Securities-Under-Supervision-Confirmation-Nichi-Iko-Pharmaceutica-42314687/?utm_medium=RSS&utm_content=20221115

Read full article »
Annual Revenue
$1.0-5.0B
Employees
1.0-5.0K
CEO Avatar

President & CEO

Yuichi Tamura

CEO Approval Rating

70/100

Read more